+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zocor"

From
Investigation Report on China's Simvastatin Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Simvastatin Market, 2019-2023

  • Report
  • February 2019
  • 30 Pages
  • China
From
Zocor - API Insight, 2022 - Product Thumbnail Image

Zocor - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zocor- Drug Insight, 2019 - Product Thumbnail Image

Zocor- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Zetia Franchise - Product Thumbnail Image

Zetia Franchise

  • Report
  • June 2018
  • 26 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Zocor is a cholesterol-lowering medication, belonging to the class of drugs known as statins. It is used to reduce the risk of cardiovascular disease, stroke, and heart attack in people with high cholesterol levels. Zocor works by blocking an enzyme in the liver that is responsible for producing cholesterol. It is typically prescribed in combination with a healthy diet and exercise. Zocor is one of the most widely prescribed statins in the world, and is available in both generic and brand-name forms. It is typically taken once daily, and is available in tablet form. Common side effects include headache, nausea, and muscle pain. The cardiovascular drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, Merck, AstraZeneca, and Novartis. Other companies include Bristol-Myers Squibb, Sanofi, and GlaxoSmithKline. Show Less Read more